Metraipolis › archive › dc_44fd5afbaa44

Effect of PEI25k/DOTAP/cholesterol liposomal formulation on the immunogenicity of SARS-CoV-2 spike protein-encoding DNA vaccine — Europe PMC PMID:42064338

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42064338
DOI
10.5114/bta/216301
License (as archived)
solo-consultazione
Archived
2026-11-05T02:21:26.596Z
SHA-256 of the archived text
82f7c605a0062cd33daa7e2802d3bc2161d041539922b57185395fc6dd343198
Stable URL of this page
https://metraipolis.com/documento/dc_44fd5afbaa44

How to cite

Effect of PEI25k/DOTAP/cholesterol liposomal formulation on the immunogenicity of SARS-CoV-2 spike protein-encoding DNA vaccine — Europe PMC PMID:42064338 — Europe PMC (en), https://europepmc.org/article/MED/42064338 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_44fd5afbaa44 (Metraipolis archive dc_44fd5afbaa44, sha256 82f7c605a0062cd33daa7e2802d3bc2161d041539922b57185395fc6dd343198)
BibTeX
@misc{dc44fd5afbaa44,
  title = {Effect of PEI25k/DOTAP/cholesterol liposomal formulation on the immunogenicity of SARS-CoV-2 spike protein-encoding DNA vaccine — Europe PMC PMID:42064338},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42064338},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_44fd5afbaa44; sha256 82f7c605a0062cd33daa7e2802d3bc2161d041539922b57185395fc6dd343198},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42064338. Agents can read the archived copy with the MCP tool read_document.